LGT Fund Management Co Ltd. lowered its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 92.6% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,050 shares of the healthcare conglomerate's stock after selling 38,139 shares during the quarter. LGT Fund Management Co Ltd.'s holdings in UnitedHealth Group were worth $952,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors have also bought and sold shares of the company. Bayforest Capital Ltd lifted its position in UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after purchasing an additional 48 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd lifted its holdings in shares of UnitedHealth Group by 416.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock worth $32,000 after acquiring an additional 50 shares during the last quarter. IAG Wealth Partners LLC bought a new stake in shares of UnitedHealth Group in the 1st quarter worth about $42,000. O Brien Wealth Partners LLC lifted its holdings in shares of UnitedHealth Group by 74.0% in the 1st quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate's stock worth $46,000 after acquiring an additional 37 shares during the last quarter. Finally, Kentucky Trust Co lifted its holdings in shares of UnitedHealth Group by 138.5% in the 1st quarter. Kentucky Trust Co now owns 93 shares of the healthcare conglomerate's stock worth $49,000 after acquiring an additional 54 shares during the last quarter. Institutional investors own 87.86% of the company's stock.
UnitedHealth Group Trading Up 1.8%
NYSE UNH opened at $360.17 on Friday. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The company has a market capitalization of $326.20 billion, a price-to-earnings ratio of 15.61, a price-to-earnings-growth ratio of 2.34 and a beta of 0.47. The company's 50-day simple moving average is $307.84 and its two-hundred day simple moving average is $354.55. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion for the quarter, compared to analysts' expectations of $111.75 billion. During the same period last year, the business posted $6.80 EPS. The company's revenue for the quarter was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were given a $2.21 dividend. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. UnitedHealth Group's payout ratio is presently 38.30%.
Wall Street Analyst Weigh In
Several equities research analysts have recently issued reports on UNH shares. Oppenheimer lowered their target price on shares of UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating for the company in a report on Wednesday, July 30th. KeyCorp decreased their price objective on shares of UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating for the company in a report on Wednesday, July 30th. Cantor Fitzgerald reiterated an "overweight" rating and set a $440.00 price objective on shares of UnitedHealth Group in a report on Tuesday, August 26th. Morgan Stanley lifted their price objective on shares of UnitedHealth Group from $325.00 to $395.00 and gave the company an "overweight" rating in a report on Friday, September 12th. Finally, Wells Fargo & Company decreased their price objective on shares of UnitedHealth Group from $306.00 to $267.00 and set an "overweight" rating for the company in a report on Monday, August 4th. Sixteen analysts have rated the stock with a Buy rating, six have given a Hold rating and four have issued a Sell rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus target price of $358.95.
Get Our Latest Stock Report on UnitedHealth Group
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.